Американское общество гирудотерапии

Chronic Anal Fissure (>8 Weeks)

Investigational adjunct for chronic anal fissure refractory to medical therapy; very limited case-report evidence; surgical sphincterotomy remains gold standard.

Tier C — InvestigationalИсследовательское применениеLast updated: 2026-05-26 · Reviewed by ASH Editorial Board

Краткая информация для пациента

Есть ли FDA-допуск для этого показания?
Not FDA-cleared for anal fissures. FDA cleared medicinal leeches only for venous congestion in microsurgical reconstruction (K040187, June 2004). Use for chronic anal fissures is investigational and considered high-infection-risk.
Какие доказательства существуют?
Tier C (investigational). Only anecdotal reports; there are no randomized controlled trials. Evidence-based therapy for chronic anal fissures per ASCRS guidelines: fiber supplementation and sitz baths, topical nitroglycerin 0.2-0.4% or topical nifedipine, botulinum toxin injection, and lateral internal sphincterotomy (gold standard for refractory disease, >90 percent cure). The perianal area is high-risk for bacterial superinfection of any breach in the skin barrier.
Основные риски
  • Severe infection risk from leech placement in the perianal area (fecal flora)
  • Bleeding from bite sites that may obscure fissure-related bleeding
  • Local skin infection or, rarely, Aeromonas infection in a contaminated area
  • Worsening of fissure pain from procedure-related trauma
  • Anal abscess or fistula formation
  • Allergic reaction to leech saliva (uncommon)
  • Delay of evidence-based topical nitroglycerin, nifedipine, botulinum toxin, or sphincterotomy
  • Risk of missed underlying inflammatory bowel disease or anorectal malignancy
Кому не следует это рассматривать
  • Patients with active perianal infection, abscess, or fistula
  • Patients with inflammatory bowel disease (Crohn perianal disease)
  • Patients with suspected anorectal malignancy
  • Patients with HIV or immunocompromise (severe infection risk)
  • Patients on anticoagulants, with hemophilia, or with severe anemia
  • Patients who have not tried topical nitroglycerin or nifedipine
  • Patients who have not been evaluated by a colorectal surgeon
О чём спросить врача
  • Has inflammatory bowel disease or anorectal malignancy been ruled out?
  • Have I tried fiber supplementation, sitz baths, and topical nitroglycerin or nifedipine?
  • Am I a candidate for botulinum toxin injection or lateral internal sphincterotomy (>90 percent cure)?
  • What is the realistic infection risk from leech placement in the perianal area?
  • What evidence specifically supports leech therapy for anal fissures?
  • What is the practitioner's antibiotic and infection-control protocol?
  • What is the cost and is it covered by insurance? (typically not covered)
Когда срочно обратиться за медицинской помощью
  • Severe perianal pain with fever (possible anal abscess — surgical emergency)
  • Persistent rectal bleeding, mucus, or pus
  • New incontinence or inability to control bowel movements
  • Spreading redness, warmth, pus, or red streaks (cellulitis or abscess)
  • Fever above 38.0 C / 100.4 F or chills
  • Bleeding from a bite site lasting more than 24 hours
  • Hives, facial or tongue swelling, throat tightness, or breathing difficulty

Что это НЕ означает

  • This is NOT FDA-cleared for anal fissures.
  • Anecdotal reports do NOT establish efficacy versus topical nitroglycerin, nifedipine, botulinum toxin, or lateral internal sphincterotomy.
  • It does NOT substitute for evidence-based pharmacologic or surgical therapy.
  • It does NOT mean perianal leech application is safe — fecal flora and abscess risk are real.
  • It does NOT replace colorectal surgical evaluation when standard therapy fails.

Перекрёстные ссылки безопасности

Clinical Profile

Category
gastrointestinal
ICD-10
K60.1
Safety tier
medium

Evidence Summary

Chronic anal fissure (>8 weeks) is conventionally treated with topical glyceryl trinitrate or diltiazem (roughly 50-60% healing), botulinum toxin injection (roughly 60-70% healing), and lateral internal sphincterotomy (the gold standard, >90% healing but with about a 10% risk of minor incontinence). No PubMed-indexed controlled trial or case report of leech therapy for anal fissure has been published; use for this indication is investigational and mechanistic only. Sphincter manometry and proctologic evaluation are appropriate before considering any complementary therapy, and IBD-related fissures require gastroenterology management.

Treatment specifics

How many leeches, where they are placed, how long a session lasts, and whether to repeat are clinical decisions made by a qualified provider under institutional protocol — not something to self-administer. Discuss the specifics with a clinician experienced in medicinal leech therapy. (Clinicians: switch the audience selector in the top bar to “Clinician” to view protocol detail.)

Key Trials

  1. Patel N et al. (2022)0

Contraindications

  • Active anticoagulant therapy (warfarin INR >2.0, DOACs, heparin)
  • Hemophilia or other bleeding disorder
  • Severe anemia (Hb <10 g/dL)
  • Active bacteremia or sepsis
  • Known hypersensitivity to leech salivary proteins
  • Pregnancy (relative — first/third trimester)
  • Immunocompromised state with severe neutropenia
  • Posterior or lateral atypical fissure (workup for IBD, malignancy)
  • Active perianal abscess or fistula
  • Crohn's disease perianal manifestation
  • Prior anal sphincter surgery with incontinence

Related Conditions

Этот сайт предоставляет образовательную информацию и не является медицинской консультацией, диагнозом или рекомендацией по лечению. Гирудотерапия сопряжена с клинически значимыми рисками и должна проводиться только квалифицированными клиницистами в рамках институционально утверждённых протоколов. Разрешение FDA 510(k) для медицинских пиявок ограничено определёнными показаниями; обсуждения исследовательского и нелицензионного применения отмечены соответствующим образом. Для индивидуальных медицинских рекомендаций обратитесь к квалифицированному медицинскому специалисту.

Chronic Anal Fissure (>8 Weeks) — Hirudotherapy Evidence | ASH